Splash Beverage enters licensing agreement with Argent BioPharma for CannEpil
Splash Beverage announced that it has entered into an exclusive global licensing agreement with Argent BioPharma for CannEpil, a proprietary, patent protected cannabinoid-based investigational therapeutic approved for the treatment of drug-resistant epilepsy in multiple European countries. As part of the transaction, S